EventsThe 3rd International Online Conference on Biomimetics
Published
This submission belongs to the session S2. Biomimetic Materials—Structures, Surfaces and Interfaces of the event The 3rd International Online Conference on Biomimetics
Published date
19 Nov, 2026
Academic Editor
author-avatarVictor Erokhin
Contribution&Funding
Conceptualization,
[Daria Nikolaevna Bogdanova]
Methodology,
[Daria Nikolaevna Bogdanova] ; [Vasilina Alexandrovna Zakharova] ; [Diana Arturovna Ahn] ; [Saida Shamilevna Karshieva]
Formal analysis,
[Daria Nikolaevna Bogdanova] ; [Vasilina Alexandrovna Zakharova] ; [Diana Arturovna Ahn] ; [Saida Shamilevna Karshieva]
Investigation,
[Saida Shamilevna Karshieva] ; [Vasilina Alexandrovna Zakharova]
Resources,
[Vasilina Alexandrovna Zakharova]
Data curation,
[Vasilina Alexandrovna Zakharova]
Writing - original draft,
[Daria Nikolaevna Bogdanova]
Writing - review,
[editing] ; [Saida Shamilevna Karshieva] ; [Daria Nikolaevna Bogdanova] ; [Vasilina Alexandrovna Zakharova]
Visualization,
[Daria Nikolaevna Bogdanova]
Supervision,
[Saida Shamilevna Karshieva] ; [Vasilina Alexandrovna Zakharova]
Project administration,
[Vasilina Alexandrovna Zakharova]
Funding: --
Citation
Daria Nikolaevna Bogdanova, Diana Arturovna Ahn, Saida Shamilevna Karshieva, Vasilina Alexandrovna Zakharova, Development of a bioresorbable microneedle patch for targeted delivery of glucocorticosteroids, in Proceedings of The 3rd International Online Conference on Biomimetics, 24 November–26 November 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Development of a bioresorbable microneedle patch for targeted delivery of glucocorticosteroids

Daria Nikolaevna Bogdanova 1
image
1. Institute of Biomedical Engineering, National University of Science and Technology MISIS, Moscow, 119049, Russia
Abstract

Glucocorticosteroids are hormonal drugs that exert broad anti-inflammatory and immunosuppressive effects, primarily by reducing the production of pro-inflammatory mediators [1]. Such drugs can be used to prevent oedema formation and the replacement of tissue with fibrotic scar following mechanical damage to organs resulting from surgical procedures.

One of the promising platforms for the localised therapeutic delivery of glucocorticosteroids to injured organs is microneedle patches of various types [2]. The development of hydrogel-based patches composed of biopolymers would not only provide an anti-inflammatory effect without metabolic transformation but also ensure adhesion to surrounding tissue due to microneedle swelling. The incorporation of extracellular matrix (ECM) into the patch composition creates a favourable microenvironment for cell viability in the damaged area, thereby promoting the restoration of tissue integrity.

First, the geometric parameters of conical microneedles (base diameter 400–600 μm, height 700–1200 μm) were selected using SOLIDWORKS software, based on simulation studies of their deformation under compression (approximately 0.06 N per needle). A Ca²⁺-crosslinked sodium alginate hydrogel supplemented with ECM and a plasticising humectant was used as the elastic base of the patch. The working concentrations and component ratios were determined by viscometry, while their interactions and compatibility were studied using potentiometry, spectrophotometry, and FTIR spectroscopy. Cell viability of NIH/3T3 fibroblasts, as well as specific cytotoxicity using primary mouse cardiomyocytes, was evaluated for each component and their combination.

Since one of the key components of the patch is lyophilised ECM obtained according to the protocol described in [3], an essential step was the assessment of its compositional purity. Haematoxylin staining was used to detect the presence of cell nuclei. qPCR and gel electrophoresis were employed to determine the amount of residual DNA and to assess DNA fragment length. Histochemical analysis confirmed the presence of major ECM components (collagen, elastic fibres, fibronectin, laminin, and glycoproteins).

To achieve an anti-inflammatory effect, a glucocorticosteroid was incorporated into the hydrogel patches, and its release kinetics were studied under physiological conditions.

Thus, a prototype of a biocompatible microneedle patch incorporating ECM and providing controlled release of a glucocorticosteroid was developed.

[1]  A. S. Fauci, ‘Mechanisms of the Immunosuppressive and Anti-Inflammatory Effects of Glucorcorticosteroids’, Journal of Immunopharmacology, vol. 1, no. 1, pp. 1–25, Jan. 1978, doi: 10.3109/08923977809027327.

[2]  D. Filho, M. Guerrero, M. Pariguana, A. Marican, and E. F. Durán-Lara, ‘Hydrogel-Based Microneedle as a Drug Delivery System’, Pharmaceutics, vol. 15, no. 10, p. 2444, Oct. 2023, doi: 10.3390/pharmaceutics15102444.

[3]  I. Belviso, ‘Human myocardium decellularization v2’, Jul. 27, 2022. doi: 10.17504/protocols.io.4r3l2o22xv1y/v2.

Keywords
microneedle patch
targeted delivery
extracellular matrix
glucocorticosteroids
Dopaminergic Wanting Modulation for Plasticity Control in a Bioinspired Taste Spiking Neural Network
Micromechanics of Reversible Insect Attachment on Plant Surfaces